Francisco Partners

News, insights, analysis and data

Francisco Partners overview

Stories about Francisco Partners

Picture of the Company

OpEx Awards 22: Americas Small-cap winner – Francisco Partners

Francisco Partners built up Trellis Rx to provide patients with speciality pharmacy services and a chronic disease management platform.

Francisco Partners contact information

Offices

marker iconOne Letterman Drive, Building C - Suite 410, San Francisco, 94129, United States
Showing 1 of 3 Francisco Partners offices

Contacts

NameJob titleLocationEmail
Key Contact
user imageMr. Andrew Brown
Job titleGlobal Head of Investor Relations & Marketing
LocationSan Francisco, United States
Emaillock image-----------
Key Contact
user imageMr. David Golob
Job titleCo-Chief Investment Officer
LocationSan Francisco, United States
Emaillock image------
Key Contact
user imageMr. Peter Kreuch
Job titleVice President, Investor Relations
LocationNew York, United States
Emaillock image-----------
user imageMr. Dipanjan Deb
Job titleCo-Founder and Chief Executive Officer
LocationSan Francisco, United States
Emaillock image-------

Francisco Partners funds managed

Closed funds: 15

FundFund sizeClose dateStrategy
Fund sizelock image-----------
Close dateJul 2026
Strategylock image----------
Fund sizelock image---------
Close dateJul 2026
Strategylock image---------
Fund sizelock image---------
Close dateJul 2022
Strategylock image--------

Stories that mention Francisco Partners

Six charts on Florida SBA's private equity programme

An inside look at the $219bn pension’s buyout and growth performance, geographic and sector exposure and co-investment portfolio.

Florida SBA meeting takes aim at limits of private equity benchmarks

Members of the $219bn pension's investment advisory council weighed in on the relevance and sufficiency of performance benchmarks at a June meeting.

Public markets: After years of private market growth, public markets may gain ground

Thanks to the evolution of a robust private market ecosystem that includes private credit, secondaries and unprecedented amounts of capital, companies are growing bigger and staying private for longer than ever before. Nevertheless, the dream to go public is still very much alive.

Seven deals signal PE’s rising appetite for patient engagement platforms

Private equity is zeroing in on healthtech investments that focus on technology-driven patient support.

Private equity maintains its penchant for tech

While three tech-focused managers sit in the PEI 300 top 10 this year, not every GP is benefiting from the same demand.

Future 40 Leaders – 2025: Operators

Introducing our 2025 Future 40 operator leaders.

Finding the exit

As GP stakes portfolios age, funds are testing out new paths to liquidity in this particularly long-term corner of the PE industry.

NYSCRF commits $2.7bn to private equity

The New York State Common Retirement Fund has backed five private equity funds.